NUVL Competitors & Alternatives
Compare Nuvalent Inc with similar stocks in the same industry
Biotechnology
NUVL
Main Stock$123.52
Tradestie Score
60
Market Cap
$5.95B
Analyst Upside
+3.7%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.74
|
$10.76B | - | 65 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$61.22
|
$10.74B | - | 60 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$57.66
|
$10.53B | 40.2 | 66 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$77.16
|
$10.49B | - | 61 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$70.04
|
$10.22B | - | 67 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$514.56
|
$10.01B | - | 60 | Compare |
|
TECH
Bio-Techne Corp.
|
$59.49
|
$9.33B | 79.4 | 56 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$80.50
|
$8.88B | 227.7 | 58 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$71.64
|
$8.77B | 24.2 | 60 | Compare |
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$168.09
|
$8.57B | - | 60 | Compare |
More NUVL Analysis
Data updated: Jun 24, 2026 | Industry: Biotechnology (SIC 2834)
224 stocks in this industry